Related Experiment Video

Updated: Apr 27, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K

MiR-20a inhibits cutaneous squamous cell carcinoma metastasis and proliferation by directly targeting LIMK1

Jianda Zhou1, Rui Liu1, Chengqun Luo1

  • 1Department of Plastic and Reconstructive Surgery; Third Xiangya Hospital; Central South University; Changsha City, Hunan, PR China.

Cancer Biology & Therapy
|July 15, 2014
PubMed
Abstract

Insights

MicroRNA-20a (miR-20a) acts as a tumor suppressor in cutaneous squamous cell carcinoma (CSCC) by inhibiting proliferation and metastasis. It directly targets LIMK1, offering potential therapeutic strategies for CSCC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNA-20a (miR-20a) has a dual role in tumorigenesis, with its specific function in cutaneous squamous cell carcinoma (CSCC) being unclear.
  • Understanding miR-20a's mechanism in CSCC is crucial for developing targeted therapies.

Purpose of the Study:

  • To elucidate the role of miR-20a in CSCC.
  • To determine if LIMK1 is a direct target of miR-20a in CSCC.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to assess miR-20a and LIMK1 expression in CSCC tissues.
  • In vitro assays (MTT, colony formation, scratch migration, transwell invasion) to evaluate miR-20a's impact on cell proliferation and metastasis.
  • Western blot and dual-luciferase reporter assays to confirm LIMK1 as a direct target of miR-20a.

Main Results:

  • miR-20a was significantly downregulated in CSCC tissues, while LIMK1 expression was upregulated.
  • Overexpression of miR-20a suppressed CSCC cell proliferation and metastasis.
  • LIMK1 was confirmed as a direct target of miR-20a, with its expression inversely correlated with miR-20a levels in CSCC specimens.

Conclusions:

  • miR-20a functions as a tumor suppressor in CSCC by directly targeting LIMK1.
  • This discovery presents miR-20a as a potential therapeutic target for CSCC treatment.
Keywords:
LIMK1cutaneous squamous cell carcinomametastasismiR-20aproliferation

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K